U.S. markets close in 4 hours 33 minutes
  • S&P 500

    4,362.92
    -70.07 (-1.58%)
     
  • Dow 30

    34,069.78
    -515.10 (-1.49%)
     
  • Nasdaq

    14,737.02
    -306.95 (-2.04%)
     
  • Russell 2000

    2,189.89
    -46.98 (-2.10%)
     
  • Crude Oil

    71.00
    -0.97 (-1.35%)
     
  • Gold

    1,766.10
    +14.70 (+0.84%)
     
  • Silver

    22.37
    +0.03 (+0.15%)
     
  • EUR/USD

    1.1740
    +0.0008 (+0.07%)
     
  • 10-Yr Bond

    1.3240
    -0.0460 (-3.36%)
     
  • GBP/USD

    1.3679
    -0.0058 (-0.43%)
     
  • USD/JPY

    109.4700
    -0.4250 (-0.39%)
     
  • BTC-USD

    43,938.73
    -3,778.25 (-7.92%)
     
  • CMC Crypto 200

    1,096.78
    -37.60 (-3.31%)
     
  • FTSE 100

    6,906.09
    -57.55 (-0.83%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

Earnings Estimates Rising for Cross Country (CCRN): Will It Gain?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Cross Country Healthcare (CCRN) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

Analysts' growing optimism on the earnings prospects of this provider of health care staffing and workforce management services is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Cross Country, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The company is expected to earn $0.03 per share for the current quarter, which represents a year-over-year change of -57.14%.

The Zacks Consensus Estimate for Cross Country has increased 233.33% over the last 30 days, as two estimates have gone higher compared to no negative revisions.

Current-Year Estimate Revisions

For the full year, the earnings estimate of $0.16 per share represents a change of +6.67% from the year-ago number.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, two estimates have moved up for Cross Country versus no negative revisions. This has pushed the consensus estimate 17% higher.

Favorable Zacks Rank

Thanks to promising estimate revisions, Cross Country currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

While strong estimate revisions for Cross Country have attracted decent investments and pushed the stock 15.1% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cross Country Healthcare, Inc. (CCRN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.